Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by coyote13on Jan 20, 2017 9:06am
332 Views
Post# 25732884

RE:RE:RE:Further to the Insider Sales

RE:RE:RE:Further to the Insider SalesHT : And your point is?

Thomvest has been active buyers of PLI paper both on the open market and with purchases concurrent with private placements pursuant to their rights negotiated as part of  their holdings of convertible debt.

Since October 30, 2016 Thomvest has made the following purchases:

                                  Shares             Price                         $                                 Type

Oct 31                   1,401,632         $2.98                 $4,176,863                    Private Placement

Nov 29                  2,000,000        $2.40                  $4,800,000                    Open Market

Nov 30                  2,000,000        $2.427                $4,854,000                   Open Market

Dec 29                 2,000,000         $1.8708             $3,741,600                    Open Market

Dec 30                 2,000,000         $2,1523             $4,304,600                    Open Market

As a result of these transactions, Thomvest now holds 19,026,406 shares plus debt convertible to common shares. No cash was received by PLI on the private placement as Thomvest exercised their right of offset to the convertible debt.  Stefan Clulow also makes a SEDI filing but it is only notional as Thomvest is the beneficial owner of the securities. In any case , you would have to agree this activity is a very strong showing of support  by Thomvest for the future prospects of PLI.

The purchase this week by Nancy Orr-Gaucher of 3,900 shares was in her TFSA, hence the small size.

So, HT while I don't expect you to become a cheerleader for PLI, try to present a balanced view of the facts. 

And by the way, the countdown is becoming more than  a little annoying. Will you cease when PLI does a partnership?

Best

Coyote13


Bullboard Posts